Friday, March 14, 2025
spot_img

Heimar hf.: Review and Confirmation by the Certifying Entity on Financial Covenants

PwC serves as the certifying entity for HEIMAR250948 and the general security arrangement. Its role includes, among other things, reviewing and confirming the issuer’s calculations in the report on financial covenants.

PwC has now conducted a review of the issuer’s calculations regarding the financial covenants of the bond series HEIMAR250948 and the general security arrangement. The conclusion of PwC’s review confirms that the bond series HEIMAR250948 and the general security arrangement comply with all financial covenants as of 31.12.2024.

Further findings from the review are included in the attached documents, which are in Icelandic.

Attachments

  • PwC staðfesting 31.12.2024 Almenna – skýrsla um fjárhagslegar kvaðir – 110325
  • PwC staðfesting 31.12.2024 Sértæka – skýrsla um fjárhagslegar kvaðir – 110325

Powered by SlickText.com

Hot this week

Bunker Hill Announces Amendment of Outstanding RSUs

KELLOGG, Idaho and VANCOUVER, British Columbia, March 13,...

Integer Holdings Corporation Announces Upsize and Pricing of Convertible Notes Offering

PLANO, Texas, March 13, 2025 (GLOBE NEWSWIRE)...

Innventure, Inc. to Attend Upcoming Roth Conference

ORLANDO, Fla., March 13, 2025 (GLOBE NEWSWIRE)...

Turtle Beach Corporation Announces Record Fourth Quarter and Year End 2024 Results

– Fourth Quarter Net Revenue Reaches Quarterly Record of...

Topics

Bunker Hill Announces Amendment of Outstanding RSUs

KELLOGG, Idaho and VANCOUVER, British Columbia, March 13,...

Innventure, Inc. to Attend Upcoming Roth Conference

ORLANDO, Fla., March 13, 2025 (GLOBE NEWSWIRE)...

Turtle Beach Corporation Announces Record Fourth Quarter and Year End 2024 Results

– Fourth Quarter Net Revenue Reaches Quarterly Record of...

21Shares to Liquidate Two ETFs

NEW YORK, NY, March 13, 2025 – 21Shares US LLC...

Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering

GAITHERSBURG, Md., March 13, 2025 (GLOBE NEWSWIRE)...

Sutro Biopharma Reports Full Year 2024 Financial Results and Business Highlights

– Sutro announced a strategic portfolio review resulting in...
spot_img

Related Articles

Popular Categories

spot_img